Hansa Biopharma
Helena Lindén Petersson is a seasoned professional in regulatory affairs with extensive experience in the biopharmaceutical industry. Currently serving as Regulatory Affairs Manager at Hansa Biopharma AB since March 2020, Helena has previously held significant roles including Director of Regulatory Affairs and Senior Regulatory Affairs Manager at Galenica AB, and Manager of Clinical Trials, Regulatory Affairs, and CMC at NeuroVive Pharmaceutical AB. Helena’s career began at AstraZeneca R&D Lund, where tenures included roles as Regulatory Affairs Manager and Senior Formulation Scientist, contributing to global regulatory submissions, clinical trial protocols, and pharmaceutical formulations. Helena holds a Master of Science in Pharmacy from Uppsala University and has a foundational background as a pharmacist at Apoteksbolaget AB.
This person is not in any teams
This person is not in any offices
Hansa Biopharma
2 followers
Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverage its unique enzyme technology to develop innovative and potentially lifesaving and life altering immunomodulating therapies for rare autoimmune conditions, transplant rejection and cancer.